GOLDMAN SACHS GROUP INC - ONCONOVA THERAPEUTICS INC ownership

ONCONOVA THERAPEUTICS INC's ticker is ONTXXXXX and the CUSIP is 68232V108. A total of 29 filers reported holding ONCONOVA THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$13,000
-23.5%
22,557
+23.5%
0.00%
Q4 2015$17,000
-46.9%
18,268
-21.7%
0.00%
Q3 2015$32,000
-47.5%
23,333
-9.8%
0.00%
Q2 2015$61,000
-19.7%
25,863
-17.4%
0.00%
Q1 2015$76,000
-8.4%
31,328
+24.7%
0.00%
Q4 2014$83,000
-20.2%
25,125
+3.8%
0.00%
Q3 2014$104,000
-71.6%
24,209
-64.0%
0.00%
Q2 2014$366,00067,3180.00%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Weiss Multi-Strategy Advisers LLC 240,872$571,0000.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 58,800$139,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 12,000$28,0000.00%
Dunvegan Associates, Inc. 560$1,0000.00%
HighTower Advisors, LLC 18,278$43,0000.00%
Horizon Kinetics 21,000$50,0000.00%
NEXT Financial Group, Inc 450$1,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11,200$27,0000.00%
Renaissance Technologies 89,400$212,0000.00%
BANK OF AMERICA CORP /DE/ 7,263$17,0000.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders